ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 655,08
1,12%
DAX
18 001,60
0,54%
Brent Oil
83,185
-0,53%
Bitcoin
61 798,36
4,54%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Oramed Pharmaceuticals Inc (ORMP)

  7. Oramed Pharmaceuticals Inc (ORMP) Actualités

ORMP Oramed Pharmaceuticals Inc

2,45
0,105 (4,48%)
Dernière mise à jour : 17:40:01
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Oramed Pharmaceuticals Inc ORMP NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,105 4,48% 2,45 17:40:01
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,38 2,38 2,45 2,345
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
19/3/202414:00GLOBEScilex Holding Company Announces Repayment in Full of the..
06/3/202423:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/2/202414:42EDGAR2Form 8-K - Current report
20/2/202414:30PRNUSOramed Letter to Shareholders
30/1/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202422:45EDGAR2Form 8-K - Current report
19/1/202422:45EDGAR2Form 8-K - Current report
08/1/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202419:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/12/202315:26EDGAR2Form 8-K - Current report
18/12/202322:45EDGAR2Form 8-K - Current report
09/11/202323:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26/9/202322:34EDGAR2Form 8-K - Current report
22/9/202317:38PRNUSSorrento Therapeutics, Inc. Announces the Consummation of..
22/9/202300:11PRNUSOramed Announces $101,875,000 Short-Term Senior Secured Note..
21/9/202322:05GLOBEScilex Holding Company Announces the Consummation of the..
13/9/202315:00GLOBEScilex Holding Company Enters into Non-Binding Term Sheets..
13/9/202314:47EDGAR2Form 8-K - Current report
10/8/202323:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202314:30EDGAR2Form 8-K - Current report
07/8/202315:20EDGAR2Form 8-K - Current report
02/8/202313:45PRNUSOramed Signs Term Sheet with HTIT to Create a Joint Venture..
13/7/202323:00EDGAR2Form 8-K - Current report
20/6/202313:55PRNUSOramed to Present at the 83rd American Diabetes Association..
18/5/202313:55PRNUSOramed to Present at Novel Therapies for Type 2 Diabetes &..
15/5/202315:05PRNUSOramed Announces that its Chinese Partner, HTIT, has..

Dernières Valeurs Consultées

NASDAQ
ORMP
Oramed Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés